Related Experiment Video
Updated: Aug 18, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
[Lactic acidosis in diabetic patient treated with metformin]
M Solano Remírez1, C González Arencibia, M Alvarez Frías
1Servicio de Medicina Interna, Hospital de Navarra, Pamplona, Navarra.
Abstract:
We present a case of metabolic acidosis in a man, recently diagnosed with type 2 diabetes mellitus under treatment with metformin. Metformin (along with Fenformin and Butformin) is an oral antihyperglycemic agent belonging to the biguanide group employed in the treatment of non insulin dependent diabetes (NIDDM). Its main use is in association with other oral agents in obese diabetic patients with difficult metabolic control. In some of these patients, clearly beneficial developed lactic acidosis, specially in those who have predisposing factors (respiratory failure, liver disease or cardiovascular disease) and/or those who require high doses. For this reason we describe its pharmacokinetics, therapeutic indications and its correct use in this type of diabetic patient.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are typically...
Diabetic Ketoacidosis l: Introduction
Diabetic Ketoacidosis ll: Pathophysiology
Diabetic Neuropathy

